Form 13-F position report

LABORATORY CRP AMER HLDGS(NEW)

Reported by MCRAE CAPITAL MANAGEMENT INC

LH CUSIP 50540R409 Manager CIK 0000320376

Reported 70,581 shares, up 413 (0.6%) from the prior quarter.

Reported value -16.2%; share count 0.6% vs. the prior quarter.

Added
% of reported 13F value 4.2% This manager · Q3 2023
Shares 70,581 Quarter-end amount reported
Reported value $14,190,335 Fair value at quarter end
Consecutive quarters held 30 Through Q3 2023

Reported position value by quarter

Reported position value by quarter

Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.

Reported position value by quarter
Date Holding Value
2021-12-31 21618000
2022-03-31 18041000
2022-06-30 15966000
2022-09-30 14065000
2022-12-31 15802063
2023-03-31 15992113
2023-06-30 16933575
2023-09-30 14190335
2023-12-31 16799491
2024-03-31 17421782
2024-06-30 0

Quarterly position history

How this manager's reported quarter-end position changed over time.

11 quarters
Quarterly reported position history for LABORATORY CRP AMER HLDGS(NEW) held by MCRAE CAPITAL MANAGEMENT INC.
Quarter Activity Shares Change % of reported 13F Reported value Filed Source filing
Q2 2024 Reduced 0 -79,748 (-100.0%) 0 $0 2024-07-24
Q1 2024 Added 79,748 +5,836 (7.9%) 3.82% $17,421,782 2024-04-18
Q4 2023 Added 73,912 +3,331 (4.7%) 4.2% $16,799,491 2024-01-22
Q3 2023 Added 70,581 +413 (0.6%) 4.2% $14,190,335 2023-10-17
Q2 2023 Added 70,168 +461 (0.7%) 4.81% $16,933,575 2023-07-21
Q1 2023 Added 69,707 +2,601 (3.9%) 4.6% $15,992,113 2023-04-19
Q4 2022 Reduced 67,106 -1,569 (-2.3%) 4.62% $15,802,063 2023-01-20
Q3 2022 Added 68,675 +551 (0.8%) 4.28% $14,065,000 2022-10-20
Q2 2022 Reduced 68,124 -301 (-0.4%) 4.33% $15,966,000 2022-07-20
Q1 2022 Reduced 68,425 -375 (-0.5%) 4.07% $18,041,000 2022-04-21
Q4 2021 Added 68,800 +590 (0.9%) 4.51% $21,618,000 2022-01-26
Five years are shown. A free account unlocks the complete reported history. Unlock full history

Who else reported the position

983 managers reported LABORATORY CRP AMER HLDGS(NEW) for Q3 2023.

Managers reporting LABORATORY CRP AMER HLDGS(NEW) in Q3 2023.
Manager Activity Shares Change % of reported 13F Reported value Tenure
BlackRock Inc Reduced 11,875,219 -828,716 0.07% $2,387,512,787 42 qtrs
VANGUARD GROUP INC Reduced 10,192,449 -133,387 0.05% $2,049,191,872 42 qtrs
STATE STREET CORPORATION Reduced 3,826,543 -104,029 0.04% $769,326,470 42 qtrs
WELLINGTON MANAGEMENT GROUP LLP Added 2,487,106 +424,684 0.1% $500,032,661 42 qtrs
MORGAN STANLEY Added 2,219,291 +1,123,755 0.05% $446,189,095 42 qtrs
LAZARD ASSET MANAGEMENT LLC Added 2,212,497 +483,878 0.61% $444,821,000 41 qtrs
GEODE CAPITAL MANAGEMENT LLC Added 1,918,727 +42,583 0.05% $384,920,671 42 qtrs
Bank of America Corporation Added 1,492,395 +23,970 0.03% $300,046,019 42 qtrs
DIMENSIONAL FUND ADVISORS LP Reduced 1,454,978 -5,192 0.1% $292,553,345 42 qtrs
JPMorgan Chase & Co Reduced 1,435,709 -950 0.03% $288,649,413 42 qtrs
Premium adds each manager's conviction percentile across reporting peers.
Filing details and methodology As reported
Report period
September 30, 2023
Filed
October 17, 2023
Filing type
13F-HR
Position type
COM NEW

Voting authority reported

Sole
0
Shared
0
None
70,581

“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.

Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.